Lysosomal Acid Lipase (LAL) Deficiency Registry
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Study ID
- NCT01633489
- Status
- Recruiting
Conditions
- Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
- Acid Lipase Deficiency
- Cholesterol Ester Storage Disease
- LAL-Deficiency
- LIPA Deficiency
- Lysosomal Acid Lipase Deficiency
- Wolman Disease
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is an observational, multi-center, international disease registry designed to collect longitudinal data and create a knowledge base that will be utilized to improve the care and treatment of patients with LAL Deficiency. Participation in the Registry by both physicians and patients is voluntary.
Key Dates
- Start date
- May 30, 2013
- Status verified
- Mar 2026
- Primary completion
- Aug 30, 2029
- Completion
- Aug 30, 2029
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: LAL Deficiency patientsPatients are those with a diagnosis of LAL Deficiency (living and deceased), irrespective of treatment status or treatment choice.
Primary Outcome Measure
Understanding of the variability, progression, identification and natural history of LAL Deficiency. [ Time Frame: Ongoing ]
Central Contacts
- Alexion Pharmaceuticals, Inc. (Sponsor)1-855-752-2356
Locations (20)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | 85016 | - |
| Clinical Trial Site | Stanford | California | 94305 | |
| Clinical Trial Site | Miramar | Florida | 33025 | - |
| Clinical Trial Site | Orlando | Florida | 32806 | - |
| Clinical Trial Site | Atlanta | Georgia | 30322 | - |
| Clinical Trial Site | Chicago | Illinois | 60611 | |
| Clinical Trial Site | Boston | Massachusetts | 02115 | |
| Clinical Trial Site | Detroit | Michigan | 48236 | |
| Clinical Trial Site | Minneapolis | Minnesota | 55404 | - |
| Clinical Trial Site | Jackson | Mississippi | 39216 | - |
| Clinical Trial Site | Hackensack, NJ, 7601 | New Jersey | 07601 | - |
| Clinical Trial Site | New York | New York | 10016 | |
| Clinical Trial Site | The Bronx | New York | 10467 | |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19104-6061 | - |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19104 | - |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19107 | - |
| Clinical Trial Site | Houston | Texas | 77030 | |
| Clinical Trial Site | Houston | Texas | 77030 | - |
| Clinical Trial Site | Snyder | Texas | 79549 | - |
| Clinical Trial Site | Tacoma | Washington | 98405 | - |
Find similar trials in Phoenix, AZ
Related Studies
- PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)PHASE1 · Recruiting · University of California, San Francisco · San Francisco, California
- ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramEnrolling By Invitation · Albert Einstein College of Medicine · Brooklyn, New York
- Registry of Patients Diagnosed With Lysosomal Storage DiseasesRecruiting · University of California, San Francisco · San Francisco, California
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina